Medical Marijuana Patient and Caregiver Notification Statement
UPDATE: Trulieve Immediately Reinstates Sales of Previously Recalled Vaporizer Cartridge in Pennsylvania After 2nd Court Decision
Trulieve Cannabis Corp. today announced it is immediately reinstating sales of botanically-derived terpene vaporizer cartridges in Pennsylvania. The Medical Marijuana Access & Patient Safety, Inc. (MMAPS), a coalition of patients and the medical cannabis industry, successfully reinstated the preliminary injunction from a judge in the Commonwealth of Pennsylvania against the Pennsylvania Department of Health (DOH) statewide recall of these products.
The Trulieve products impacted by the recall were its Modern Flower and Liquid Moxie brands containing botanically-derived terpenes in the form of vaporizer cartridges.
"This ruling reinforces the first court victory and is a win for medical marijuana patients in Pennsylvania," said Trulieve’s Chief Executive Officer Kim Rivers. "The Court’s decision allows medical marijuana patients in the Commonwealth to have continued access to a proven and third-party tested medical marijuana product. The previously recalled products had been approved by the Pennsylvania Department of Health for more than four years and are currently being used safely in other states. While the DOH will likely further appeal this decision, we will continue to fight for patient rights.”
Trulieve operates dispensaries located in the following communities around the Commonwealth: Camp Hill, Coatesville, Cranberry Township, Devon, Harrisburg, Johnstown, King of Prussia, Pittsburgh, Philadelphia, Reading, Scranton, Washington, Whitehall, York and Zelienople.
For more information about the recall and MMAPS initial Court victory, please visit our previous Statement found here.